AbbVie sets aside $2 billion to settle U.S. opioid claims
July 29 (Reuters) - AbbVie Inc has set aside about $2 billion to resolve thousands of lawsuits against its Allergan unit over the marketing of its opioid...
July 29 (Reuters) - AbbVie Inc has set aside about $2 billion to resolve thousands of lawsuits against its Allergan unit over the marketing of its opioid...